FHLC News and Press, Fidelity MSCI Health Care Index From 04/03/19

Pharmaceutical companies are continuing to defy political pressure from both Democrats and Republicans by raising the prices of almost 3,000 drugs in the U.S. in the first three months of this year. More news on: Health Care Select Sect SPDR ETF, iShares U.S. Healthcare ETF, Vanguard Hea...

By Vinay Thapar Healthcare stocks served as powerful painkillers during last year's market declines. Yet the sector offers much more than just downside protection for investors who focus on business potential and resist the urge to predict scientific breakthroughs. While the MSCI World I...

By Ethan Lovell and Rich Carney, CFA The U.S. Department of Health and Human Services wants to eliminate drug manufacturer rebates in Medicare, a move that could improve affordability for consumers. Portfolio Manager Ethan Lovell and Research Analyst Rich Carney, of the Global Life Scienc...

For those of you investing in Big Pharma, you may want to keep a close eye on developments in Washington over the next two years. The cost of pharmaceuticals may very well be the number one issue leading up to the 2020 election, and this year it may very well be different. This year, the Dem...

By Antonio (Tony) Docal, CFA, Director of Portfolio Management, Templeton Global Equity Group® and Heather Arnold, CFA, Director of Research, Portfolio Manager, Templeton Global Equity Group® The market environment for value investors over the past few years has been less than id...

To be fair, we’re only a little more than halfway through the fourth quarter’s earnings season. Much could still change on the proverbial ‘back nine.’ On the other hand, with most of the major names already reporting last quarter’s results, where we are is ...

Megatrends Podcast Series Globalization has made the world we live in very small, and very connected. Market trends are global, companies are innovating faster than ever, and money managers are paying very close attention. In each episode, author and hedge-fund specialist Maneet A...